| 47.33 Data as of 12:09pm ET |  -0.10 / -0.21%Today’s Change | 36.05 Today|||52-Week Range 48.16 | +19.13% Year-to-Date |
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
| 1 month | +2.53% | 3 years | -- | |
| 3 months | +12.07% | 5 years | -- | |
| 1 year | +33.16% | Since inception | +25.17% |
| Previous close | $47.43 |
| Open day’s range | 46.99 – 47.33 |
| Net asset value (NAV) | 47.44 (05/22/2013) |
| Daily volume | 80,207 |
| Average volume (3 months) | 74,746 |
| PPH | Category | |
|---|---|---|
| Performance 5-yr return | -- | +13.03% |
| Expense Gross exp ratio | 0.41% | 0.47% |
| Risk 5 year sharpe ratio | -- | 0.75 |
| Net assets | $277.3M | $776.1M |
| Average market cap | $83.5B | $19.4B |
| Average P/E | 19.6 | 21.6 |
| Dividend / Share | -- | 0.22% |
| No competitors data available. |
| Business service | -- |
| Consumer goods | -- |
| Consumer service | -- |
| Energy | -- |
| Financial service | -- |
| JNJ Johnson & Johnson | 12.03% |
| PFE Pfizer Inc | 10.62% |
| NVS Novartis AG ADR | 8.96% |
| MRK Merck & Co Inc | 7.06% |
| SNY Sanofi ADR | 6.23% |
| GSK GlaxoSmithKline PLC ADR | 6.13% |
| ABBV AbbVie Inc | 5.16% |
| AZN AstraZeneca PLC ADR | 4.82% |
| ABT Abbott Laboratories | 4.60% |
| BMY Bristol-Myers Squibb Company | 4.50% |
.
